SFTPC and lung adenocarcinoma: This subset of patients is distinguishable clinically by earlier-onset disease in young adults associated with surfactant protein C (SFTPC) mutations and a history of lung adenocarcinoma being associated with surfactant protein A1 and A2 (SFTPA1 and SFTPA2) mutations.